Axsome Therapeutics AXSM Change in Inventories
Change in Inventories at other companies
Other financials
Where this comes from
Reported directly by Axsome Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInInventories.
The official record: Axsome Therapeutics’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Axsome Therapeutics's change in inventories.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Axsome Therapeutics's change in inventories?
- Axsome Therapeutics (AXSM) reported change in inventories of $3.11M in Q1 2026.
- How has Axsome Therapeutics's change in inventories changed year-over-year?
- Axsome Therapeutics's change in inventories increased by 1149.0% year-over-year, from $249K to $3.11M.
- What does change in inventories mean?
- The net change in the value of goods held in stock.
- How do you interpret change in inventories?
- An increase indicates inventory buildup, which consumes cash, while a decrease indicates inventory liquidation, which generates cash.
- How does change in inventories compare across companies?
- Common in manufacturing and commercial-stage biopharma; high levels relative to sales may indicate potential obsolescence risk.